MeSH term | MeSH ID | Detail |
---|---|---|
Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Dermatitis, Atopic | D003876 | 19 associated lipids |
Eriodictyol is a lipid of Polyketides (PK) class. Eriodictyol is associated with abnormalities such as Hyperostosis, Diffuse Idiopathic Skeletal, Macular degeneration, Consumption-archaic term for TB, Retinal Diseases and PARAGANGLIOMAS 4. The involved functions are known as glutathione biosynthetic process, Cytoprotection, Oxidants, protein expression and Cell Survival. Eriodictyol often locates in Cytoplasmic matrix, Protoplasm, Cytoplasmic, Cell Fraction and Back. The associated genes with Eriodictyol are NQO, HMOX1 gene, IMPACT gene, RPS6KA3 gene and GDNF gene.
To understand associated biological information of ERIODICTYOL, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
ERIODICTYOL is suspected in Macular degeneration, Retinal Diseases, PARAGANGLIOMAS 4 and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with ERIODICTYOL
MeSH term | MeSH ID | Detail |
---|---|---|
Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Dermatitis, Atopic | D003876 | 19 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Bonaterra GA et al. | In vitro anti-proliferative effects of the willow bark extract STW 33-I. | 2010 | Arzneimittelforschung | pmid:20648923 |
Ferreira Ede O et al. | Neuroinflammatory response to experimental stroke is inhibited by eriodictyol. | 2016 | Behav. Brain Res. | pmid:27353856 |
Kobayashi S and Konishi Y | Transepithelial transport of flavanone in intestinal Caco-2 cell monolayers. | 2008 | Biochem. Biophys. Res. Commun. | pmid:18190788 |
Kasai N et al. | Enzymatic properties of cytochrome P450 catalyzing 3'-hydroxylation of naringenin from the white-rot fungus Phanerochaete chrysosporium. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19576179 |
Lee JK et al. | Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. | 2009 | Biochem. Pharmacol. | pmid:19426678 |
Rossato MF et al. | Eriodictyol: a flavonoid antagonist of the TRPV1 receptor with antioxidant activity. | 2011 | Biochem. Pharmacol. | pmid:21087598 |
Ko WC et al. | Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. | 2004 | Biochem. Pharmacol. | pmid:15476679 |
van Zanden JJ et al. | Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. | 2005 | Biochem. Pharmacol. | pmid:15670588 |
Bucolo C et al. | Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. | 2012 | Biochem. Pharmacol. | pmid:22484312 |
van Zanden JJ et al. | Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. | 2004 | Biochem. Pharmacol. | pmid:15041478 |